National Health (Listed drugs on FI or F2) Amendment Determination 2015 (No.11) (PB 123 of 2015) (Cth)

PB 123 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 11)

National Health Act 1953

I, GREG O’TOOLE, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated        21     December 2015

GREG O’TOOLE

Assistant Secretary (Acting)
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 11).

   (2)   This Determination may also be cited as PB 123 of 2015.

2. Commencement

   This Determination commences on 1 January 2016.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Alogliptin

Omit

Aluminium hydroxide with magnesium trisilicate and magnesium hydroxide

[2]     Schedule 1, after item dealing with Amino acid formula with vitamins and minerals and long chain polyunsaturated fatty acids without phenylalanine

Omit

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic

Insert

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid

[3]     Schedule 1, after item dealing with Chlorambucil

Omit

Chloramphenicol

[4]     Schedule 1, after item dealing with Ferric carboxymaltose

Omit

Ferrous Fumarate

[5]     Schedule 1, after item dealing with Levodopa with benserazide

Omit

Levonorgestrol

Insert

Levonorgestrel

[6]     Schedule 1, after item dealing with Pembrolizumab

Omit

Pemetrexed

[7]     Schedule 1, after item dealing with Reteplase

Insert

Ribavirin and peginterferon alfa-2b

[8]     Schedule 2, after item dealing with Paroxetine

Insert

Pemetrexed